BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26457625)

  • 1. Practical Applications in Immunohistochemistry: Carcinomas of Unknown Primary Site.
    Kandalaft PL; Gown AM
    Arch Pathol Lab Med; 2016 Jun; 140(6):508-23. PubMed ID: 26457625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach.
    DeYoung BR; Wick MR
    Semin Diagn Pathol; 2000 Aug; 17(3):184-93. PubMed ID: 10968704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUP: looking for a missing primary site and its biology.
    Pentheroudakis G
    Ann Oncol; 2012 Sep; 23 Suppl 10():x278-81. PubMed ID: 22987976
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous Metastases: A Review and Diagnostic Approach to Tumors of Unknown Origin.
    Habermehl G; Ko J
    Arch Pathol Lab Med; 2019 Aug; 143(8):943-957. PubMed ID: 30605024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinoma of unknown primary. Role of the pathologist in 2018: Introduction].
    Selves J; Long-Mira E; Mathieu MC; Rochaix P; Ilié M
    Ann Pathol; 2018 Jun; 38(3):164-197. PubMed ID: 29929740
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.
    Oien KA; Dennis JL
    Ann Oncol; 2012 Sep; 23 Suppl 10():x271-7. PubMed ID: 22987975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Immunohistochemistry in Undifferentiated Neoplasms: A Practical Approach.
    Kandukuri SR; Lin F; Gui L; Gong Y; Fan F; Chen L; Cai G; Liu H
    Arch Pathol Lab Med; 2017 Aug; 141(8):1014-1032. PubMed ID: 28745568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma of unknown primary (CUP): an update for histopathologists.
    Beauchamp K; Moran B; O'Brien T; Brennan D; Crown J; Sheahan K; Cotter MB
    Cancer Metastasis Rev; 2023 Dec; 42(4):1189-1200. PubMed ID: 37394540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
    Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
    Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.
    Greco FA
    Curr Treat Options Oncol; 2013 Dec; 14(4):634-42. PubMed ID: 23990214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry.
    Conner JR; Hornick JL
    Adv Anat Pathol; 2015 May; 22(3):149-67. PubMed ID: 25844674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic management of inaugurable metastases].
    Penel N
    Presse Med; 2003 Jun; 32(21):990-6, 1004. PubMed ID: 12876530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary.
    Nguyen TT; Kreisel FH; Frater JL; Bartlett NL
    J Clin Oncol; 2013 Nov; 31(33):e443-5. PubMed ID: 23775969
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic evaluation of patients with carcinoma of unknown primary tumor site.
    Leonard RJ; Nystrom JS
    Semin Oncol; 1993 Jun; 20(3):244-50. PubMed ID: 8503020
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
    Varadhachary GR; Talantov D; Raber MN; Meng C; Hess KR; Jatkoe T; Lenzi R; Spigel DR; Wang Y; Greco FA; Abbruzzese JL; Hainsworth JD
    J Clin Oncol; 2008 Sep; 26(27):4442-8. PubMed ID: 18802157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice.
    Chen ZE; Lin F
    Arch Pathol Lab Med; 2015 Jan; 139(1):14-23. PubMed ID: 25549141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.
    Handorf CR; Kulkarni A; Grenert JP; Weiss LM; Rogers WM; Kim OS; Monzon FA; Halks-Miller M; Anderson GG; Walker MG; Pillai R; Henner WD
    Am J Surg Pathol; 2013 Jul; 37(7):1067-75. PubMed ID: 23648464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic approach to cancer of unknown primary site].
    Fernández Cotarelo MJ; Guerra Vales JM
    Rev Clin Esp; 2009; 209(7):347-51. PubMed ID: 19709540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategies for carcinoma of unknown primary: the role of tissue-of-origin molecular profiling.
    Varadhachary G
    Clin Cancer Res; 2013 Aug; 19(15):4027-33. PubMed ID: 23519898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A; Xue J; Hu M; Zheng J; Wang X
    Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.